Affiliation:
1. Fourth Hospital of Hebei Medical University
Abstract
Abstract
Background
Microvascular invasion (MVI) is an important step in cancer cell migration and invasion, and it is also a significant factor in predicting tumor recurrence and prognosis. Building a nomogram based on CT image features and clinicopathological data to predict preoperative MVI in gastric cancer (GC).
Methods
Retrospective study enrolled 358 patients with surgically proven GC. Univariate and multivariate logistic regression analyses were performed to identify the predictors for the model and establish a nomogram for MVI. The performance of the model was evaluated using ROC, accuracy, and C index. Internal validation of the model was conducted using the bootstrap resampling method. Difference in the area under the curve (AUC) between the two models was evaluated using the Delong test. Random forest algorithm is used to extract important risk factors for MVI.
Results
Mural stratification, Lauren classification and Albumin (Alb) were found to be independent influencing factors for MVI. The nomogram model incorporating these three factors showed significantly better performance compared to the original model that did not include CT parameters (P < 0.05). The AUC of the model was 0.779 (95% CI 0.774–0.868), and the average AUC of the bootstrap sample was 0.813. The sensitivity, specificity, and accuracy of the model were 65.6%, 86.0%, and 70.7%, respectively.
Conclusion
The nomogram based on CT image features and clinicopathological data demonstrated good predictive value for MVI in GC. This nomogram can provide valuable baseline information for individualized treatment of GC.
Publisher
Research Square Platform LLC
Reference37 articles.
1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Ajani JA;J Natl Compr Cancer Network: JNCCN,2022
2. Zheng Y, Yang X, Yan C et al. (2020). Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial. European journal of cancer (Oxford, England: 1990), 130, 12–19. https://doi.org/10.1016/j.ejca.2020.02.013.
3. Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis;Grizzi G;Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,2022
4. A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer;AGNES A;J Surg Oncol,2020
5. A Novel Nomogram for Individually Predicting of Vascular Invasion in Gastric Cancer;Meng Y;Technol Cancer Res Treat,2021